Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip 
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal 
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves 
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop 
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns 
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens 
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales 
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan 
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns 
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results 
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets 
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management 
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August 
Jetstar to Charge for Overhead Cabin Bags From February 
Apple Restores Telegram to App Store After Content Policy Violation 
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations 
DHL Q2 Profit Jumps 24% as Express Business Drives Growth 
Global Bioenergies to present results of engine testing with renewable fuels
Evry (France) -March 22nd, 2018 - Global Bioenergies (Euronext Growth: ALGBE) will present engine testing results on April 5th. Its commercial partner Audi, and German engine & fuels specialist FEV, will join the presentation.
About GLOBAL BIOENERGIES
Global Bioenergies is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation. The Company initially focused its efforts on the production of isobutene, one of the most important petrochemical building blocks that can be converted into fuels, plastics, organic glass and elastomers. Global Bioenergies continues to improve the performance of its process, to operate its demo plant in Germany, and to prepare the first full-scale plant through a joint venture with Cristal Union, named IBN-One. Global Bioenergies is listed on Euronext Growth Paris (FR0011052257 - ALGBE).
Stay informed! Subscribe to our newsfeed on
www.global-bioenergies.com
Follow us on Twitter: @GlobalBioenergi
Contact
GLOBAL BIOENERGIES
Luc Mathis
Chief Business Officer
Phone: +33 1 64 98 20 50
[email protected]
Attachment:
http://www.globenewswire.com/NewsRoom/AttachmentNg/0a769082-ac92-468a-b97c-ab76ce652e8a
